Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MINISO Group Holding Ltd (MNSO) vs Smith & Nephew plc (SNN) Price & Performance

MINISO Group Holding LtdTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

MINISO Group Holding Ltd vs Smith & Nephew plc — how do they compare? MINISO Group Holding Ltd trades at $11.97 (market cap $3.62B), while Smith & Nephew plc trades at $29.95 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 3.5× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (5.53%). Which is the better fit depends on your goals.

MNSOSNN
Market Cap
$3.62B$12.54B
Sector
TechnologyHealth
52-Week High
$26.63$38.70
52-Week Low
$11.30$28.73
Enterprise Value
$4.29B$15.57B
Dividend Yield
5.53%2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MINISO Group Holding Ltd

No Aura AI signal available yet.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.

Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.

Returns comparison

Trailing returns across standard periods

About MINISO Group Holding Ltd

MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.

Read more on MNSO

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN